A non-CME virtual event sponsored by Daiichi Sankyo Advances in AML Series: Discussion on QuANTUM-First. Hear from top experts in your field.
REGISTER NOW
FLT3-ITD Mutations in AML
FLT3 Mutation Testing
Evolving Treatment Landscape
Mechanism of Action
FLT3 Selectivity
Study Design
Overall Survival
CR and CRc
Duration of CR
RFS
Common Adverse Reactions
VANFLYTA REMS
Dosing Snapshot
ECG and Electrolyte Monitoring
Administration
Titration and Dose Modifications
Access Central
Clinical Resources
How to Procure VANFLYTA
The site you are linking to is not controlled or endorsed by Daiichi-Sankyo, and we are not responsible for the content.
Thank you for visiting.
